Skip to Content

A new RSV shot for infants is in short supply

AP Medical Writer

NEW YORK (AP) — A new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease. The one-time shot is called Beyfortus. It was developed by AstraZeneca and Sanofi. It contains a lab-made antibody that helps the immune system fight off the virus. RSV is a common cause of coldlike symptoms, but it can be dangerous for young children. A seasonal virus, it’s already widely reported in the southern United States and is expected to continue to spread over the next month or two.

Article Topic Follows: AP-National

Jump to comments ↓

Associated Press


KVIA ABC 7 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content